Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

Abstract

This review mainly focuses on the comparative study of both the therapeutic and adverse impacts of NSAIDs for pulmonary disorders. NSAIDs are being used by almost 30 million of people on a regular basis not only for their efficacy in reducing pain and inflammation but also pulmonary disorders like CF, COPD, NSCLC etc. having the association of high risk factors with asthma patients, SCLC, PE, pleuropulmonary complications and pregnant and breast feeding women. All the data being used in this review has been taken from published research paper, articles in the reputed journals and research databases like pubmed, sciencedirect, scopus etc. To ensure more efficient and better treatment opportunity continuous research, desensitization techniques, new dosage form and technologies are required. Considering all the potential benefits of using NSAIDs, approaches for targeted pulmonary route of administration would be the key to balancing the risk and benefits of NSAIDs for pulmonary diseases.